bluebird bio (NASDAQ: BLUE) is trading down after peer Juno Therapeutics, Inc. (Nasdaq: JUNO) announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE